Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer

Journal of Urology

Volumn 171, Issue 1, 2004, Pages 149-152

  Kwak, Cheol ^a,b   Ku, Ja Hyeon ^c   Park, Jae Young ^c   Lee, Eunsik ^a,b,c   Lee, Sang Eun ^a,b,c   Lee, Chongwook ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Bladder; Bladder neoplasms; Carcinoma, transitional cell; Neoplasm staging; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME;

EID: 0347479287     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000099825.98542.a8     Document Type: Article

References (20)

1. Greenlee, R. T., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 2000. Ca Cancer J Clin, 50: 7, 2000
2. Jakse, G., Loidl, W., Seeber, G. and Hofstädter, F.: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol, 137: 39, 1987
3. Eure, G. R., Cundiff, M. R. and Schellhammer, P. F.: Bacillus Calmette-Guerin therapy for high risk stage T1 superficial bladder cancer. J Urol, 147: 376, 1992
4. Lebret, T., Gaudez, F., Herve, J. M., Barre, P., Lugagne, P. M. and Botto, H.: Low-dose BCG instillation in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success. Eur Urol, 34: 67, 1998
5. Althausen, A. F., Prout, G. R., Jr. and Daly, J. J.: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol, 116: 575, 1976
6. Shahin, O., Thalmann, G. N., Rentsch, C., Mazzucchelli, L. and Studer, U. E.: A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol, 169: 96, 2003
7. Sobin, L. H. and Wittekind, C.: Urinary bladder. In: TNM Classification of Malignant Tumours, 5th ed. International Union Against Cancer. New York: Wiley-Liss, p. 187, 1997
8. Reuter, V. E., Epstein, J. I., Amin, M. B. and Mostofi, F. K.: The "WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion. Hum Pathol, 30: 879, 1999
9. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J Amer Stat Ass, 53: 457, 1958
10. Cookson, M. S., Herr, H. W., Zhang, Z.-F., Soloway, S., Sogani, P. C. and Fair, W. R.: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol, 158: 62, 1997
11. Herr, H. W., Schwalb, D. M., Zhang, Z. F., Sogani, P. C., Fair, W. R., Whitmore, W. F., Jr. et al: Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol, 13: 1404, 1995
12. Kondylis, F. I., Demirci, S., Ladaga, L., Kolm, P. and Schellhammer, P. F.: Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol, 163: 1120, 2000
13. Pansadoro, V., Emiliozzi, P., de Paula, F., Scarpone, P., Pansadoro, A. and Sternberg, C. N.: Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology, 59: 227, 2002
14. Brake, M., Loertzer, H., Horsch, R. and Keller, H.: Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmmette-Guerin. J Urol, 163: 1697, 2000
15. Baniel, J., Grauss, D., Engelstein, D. and Sella, A.: Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder. Urology, 52: 785, 1998
16. Cookson, M. S. and Sarosdy, M. F.: Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J Urol, 148: 797, 1992
17. Patard, J., Moudouni, S., Saint, F., Rioux-Leclercq, N., Manunta, A., Guy, L. et al: Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years. Urology, 58: 551, 2001
18. Hurle, R., Losa, A., Manzetti, A. and Lembo, A.: Intravesical bacille Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7-year follow-up. Urology, 54: 258, 1999
19. Zbar, B., Bernstein, I. D. and Rapp, H. J.: Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guerin. J Natl Cancer Inst, 46: 831, 1971
20. Klän, R., Loy, V. and Huland, H.: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol, 146: 316, 1991